Grafnos 0.25mg Capsule
Marketer
Akognos Life Sciences
Salt Composition
Tacrolimus (0.25mg)
Overview Grafnos 0.25mg Capsule
Following an organ transplant (liver, kidney, heart, etc.), Immunosuppressant capsules of Grafnos 0.25mg are administered alongside other medications to prevent organ rejection. By suppressing the immune system, it reduces the risk of the body attacking the new organ. Dosage and frequency of Grafnos 0.25mg depend on your transplant type, weight, and other medications, as directed by your physician. For optimal absorption, take it on an empty stomach, at least one hour before or two hours after eating. Consistent use is crucial; discontinuation increases rejection risk. Grafnos 0.25mg can cause or exacerbate diabetes and kidney issues, requiring immediate medical attention. Other potential side effects include tremors, infections, hypertension, headaches, and sleep disturbances. Report any persistent or worsening side effects to your doctor. Grafnos 0.25mg weakens immunity, increasing infection susceptibility. Prior to treatment, inform your doctor about any pre-existing kidney, liver, heart conditions, diabetes, or hypertension, and all other medications (including those for infections, pain, or arthritis) as interactions may occur. Minimize sun and UV exposure due to increased skin cancer risk. Effective contraception is advised for both men and women. Use during pregnancy and breastfeeding is generally discouraged unless medically necessary. Regular blood pressure checks and monitoring via frequent blood tests are essential throughout treatment.
Uses of Grafnos 0.25mg Capsule
Preventing graft rejection in recipients of organ transplants
Major Benefits of Grafnos 0.25mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Grafnos 0.25mg Capsules on an empty stomach.
Common Side effects of Grafnos 0.25mg Capsule:
- High blood pressure
- Increased glucose level in blood
- Kidney damage
- Insomnia (difficulty in sleeping)
- Tremors
- Headache
- Abnormal liver function tests
- Infection
How to use Grafnos 0.25mg Capsule:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Consume Grafnos 0.25mg Capsules on an empty stomach.
How Grafnos 0.25mg Capsule works:
Immunosuppressant Grafnos 0.25mg capsules reduce the body's immune reaction after organ transplantation (such as liver, kidney, or heart). This action promotes the body's acceptance of the transplanted organ.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Grafnos 0.25mg Capsules is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Grafnos 0.25mg Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Grafnos 0.25mg Capsules while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a 0.25mg Grafnos capsule might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Exercise caution when administering 0.25mg Grafnos capsules to individuals with impaired renal function. Dosage modification of 0.25mg Grafnos capsules may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Grafnos 0.25mg capsules; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Grafnos 0.25mg Capsule :
Should you forget a Grafnos 0.25mg Capsule dose, administer it at your earliest convenience. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Grafnos 0.25mg Capsule
| Label | Value |
|---|---|
| Chemical Category | Macrolide Antibiotics |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |






